Antitumor Activity of Gefitinib in Malignant Rhabdoid Tumor Cells <b> <i>In vitro</i> </b> and <b> <i>In vivo</i> </b>

Abstract

Our results demonstrate that gefitinib has antitumor effects in MRT cells in vitro and in vivo and, thus, has promise as a novel and therapeutic strategy for MRT.